Literature DB >> 11810028

Effects of HIV-1 Nef on cellular gene expression profiles.

Syed Shaheduzzaman1, Vyjayanthi Krishnan, Ana Petrovic, Michael Bittner, Paul Meltzer, Jeffrey Trent, Sundararajan Venkatesan, Steven Zeichner.   

Abstract

The early human immunodeficiency virus (HIV) accessory protein Nef makes an important contribution to virulence, but the mechanisms by which Nef influences pathogenesis remain unclear. Many well-studied effects of Nef, like CD4 and class I MHC downregulation, occur posttranslationally. However, Nef has the potential to affect gene expression by interfering with cell signaling pathways and by virtue of structural features such as the Pro-X-X-Pro motif, which may interact with src homology region-3 domains of src-like kinases. We used a cDNA microarray screening strategy to identify cellular genes whose steady state transcriptional levels may be affected by Nef. We generated HeLa cell lines expressing wild-type or mutant HIV-1 nef protein sequences. Using cDNA microarray technology, we compared the patterns of cellular gene expression in the various cell lines to the pattern in non-Nef-expressing HeLa cells. By matching the patterns of cellular gene expression in HeLa cell lines expressing various Nefs with that of parental HeLa cells, we identified several cellular genes whose expression was modulated differentially by Nef and its mutants. We confirmed the differential expression of selected genes by RNA filter blotting. Genes expressed at higher levels included proteases, transcription factors, protein kinases, nuclear import/export proteins, adaptor molecules and cyclins, some of which have previously been implicated as being important for HIV replication and pathogenesis. The results indicate that Nef expression can alter the expression of cellular genes and suggest that this alteration in cellular gene expression may serve to optimize the cell to support the subsequent stages of viral replication. Copyright 2002 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11810028     DOI: 10.1007/bf02256581

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  7 in total

1.  Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation.

Authors:  Zahedi Mujawar; Norimasa Tamehiro; Angela Grant; Dmitri Sviridov; Michael Bukrinsky; Michael L Fitzgerald
Journal:  Biochemistry       Date:  2010-09-28       Impact factor: 3.162

2.  Patterns of HIV-1 protein interaction identify perturbed host-cellular subsystems.

Authors:  Jamie I MacPherson; Jonathan E Dickerson; John W Pinney; David L Robertson
Journal:  PLoS Comput Biol       Date:  2010-07-29       Impact factor: 4.475

3.  Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.

Authors:  Vyjayanthi Krishnan; Steven L Zeichner
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

4.  N-Myristoyltransferase isozymes exhibit differential specificity for human immunodeficiency virus type 1 Gag and Nef.

Authors:  Kelly E Seaton; Charles D Smith
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

5.  The simian immunodeficiency virus targets central cell cycle functions through transcriptional repression in vivo.

Authors:  Carl-Magnus Hogerkorp; Yoshiaki Nishimura; Kaimei Song; Malcolm A Martin; Mario Roederer
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

6.  Characterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency.

Authors:  Sandie Munier; Delphine Delcroix-Genête; Laëtitia Carthagéna; Audrey Gumez; Uriel Hazan
Journal:  Retrovirology       Date:  2005-11-23       Impact factor: 4.602

7.  Microarray study reveals that HIV-1 induces rapid type-I interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells.

Authors:  Michaël Imbeault; Michel Ouellet; Michel J Tremblay
Journal:  Retrovirology       Date:  2009-01-15       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.